Mangosteen juice blend for the reduction of inflammation in obese subjects: a randomised, double-blind, placebo-controlled, dose finding study

XanGo, LLC (USA)0 个研究点目标入组 40 人开始时间: 2009年8月19日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Aged between 30 - 75 years of age, either sex
•2. Body mass index (BMI) greater than 30 and less than 45 kg/m^2 (obese)
•3. A high sensitivity C-reactive protein (HS-CRP) of greater than 3
•4. Agreed to discontinue anti-inflammatory medications and supplements (other than daily 81 mg aspirin, which was allowed)
•5. Agreed to use approved birth control methods if a female of childbearing age
•6. Agreed to not initiate or change any exercise or diet programs during the study

•1. Subjects were excluded if they had consumed the test product in the past
•2. Had allergies to the test product
•3. Using any drugs that can affect CRP
•4. Were taking hormone replacements, anticoagulants or anti-platelet therapy
•5. Had surgery in the past 6 months
•6. Smoked cigarettes
•7. Known alcohol or drug abuse
•8. Had major systemic, inflammatory or chronic disease
•9. Untreated depression
•10. Active eating disorder
•11. Unable to understand or follow study protocol
•12. Pregnant or lactating
•13. Any medical condition which, in the opinion of the investigator, might interfere with the subject's ability in the trial

发起方

XanGo, LLC (USA)